Evidence map›Paper›PMID 23499866›Full record

ReviewMolecular and cellular endocrinology2013

The genetic basis of female reproductive disorders: etiology and clinical testing.

Lawrence C Layman

Abstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Increased homozygosity due to endogamy results in fitness consequences in a human population.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The future for genetic studies in reproduction.Molecular human reproduction · 2014
    Review
  17. The Genetics of Infertility: Current Status of the Field.Current genetic medicine reports · 2013
    Article
  18. Clinical genetic testing for Kallmann syndrome.The Journal of clinical endocrinology and metabolism · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lawrence C LaymanSection of Reproductive Endocrinology, Infertility, & Genetics, Department of Obstetrics & Gynecology, Institute of Molecular Medicine and Genetics, Neuroscience Program, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA. lalayman@gru.edu

Funding

Genetics of Delayed Puberty.R01HD033004 · NICHD · MEDICAL COLLEGE OF GEORGIA (MCG) · PI LAYMAN, LAWRENCE C · 2003 to 2014
$3.1M
GENETICS OF DELAYED PUBERTYR29HD033004 · NICHD · UNIVERSITY OF CHICAGO · PI LAYMAN, LAWRENCE C · 1997 to 2001
$213k
NICHD NIH HHS HD33004NICHD NIH HHS R01 HD033004NICHD NIH HHS R29 HD033004
6 · The paper itself

Abstract

With the advent of improved molecular biology techniques, the genetic basis of an increasing number of reproductive disorders has been elucidated. Mutations in at least 20 genes cause hypogonadotropic hypogonadism including Kallmann syndrome in about 35-40% of patients. The two most commonly involved genes are FGFR1 and CHD7. When combined pituitary hormone deficiency includes hypogonadotropic hypogonadism as a feature, PROP1 mutations are the most common of the six genes involved. For hypergonadotropic hypogonadism, mutations in 14 genes cause gonadal failure in 15% of affected females, most commonly in FMR1. In eugonadal disorders, activating FSHR mutations have been identified for spontaneous ovarian hyperstimulation syndrome; and WNT4 mutations have been described in mullerian aplasia. For other eugonadal disorders, such as endometriosis, polycystic ovary syndrome, and leiomyomata, specific germline gene mutations have not been identified, but some chromosomal regions are associated with the corresponding phenotype. Practical genetic testing is possible to perform in both hypogonadotropic and hypergonadotropic hypogonadism and spontaneous ovarian hyperstimulation syndrome. However, clinical testing for endometriosis, polycystic ovary syndrome, and leiomyomata is not currently practical for the clinician.

Indexed as

46, XX Disorders of Sex DevelopmentCongenital AbnormalitiesDisorders of Sex DevelopmentDNA-Binding ProteinsDNA HelicasesEndometriosisFemaleFragile X Messenger Ribonucleoprotein 1Genital Diseases, FemaleHomeodomain ProteinsHumansHypogonadismLeiomyomaMaleMullerian DuctsOvarian Hyperstimulation SyndromeCHD7 protein, humanDNA-Binding ProteinsDNA HelicasesFGFR1 protein, humanFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Homeodomain ProteinsPituitary Hormones, AnteriorProphet of Pit-1 proteinReceptor, Fibroblast Growth Factor, Type 1Wnt4 ProteinWNT4 protein, human

Identifiers

PMID23499866
PMCPMC3767392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.